相关实验视频

Updated: Jun 23, 2025

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

针对子宫内膜癌的小分子向疗法:进展,挑战和机会

Fei-Fei Yang¹, Tian-Tian Zhao², Slieman Milaneh^2,3

¹Yixing People's Hospital Yixing Jiangsu 214200 China.

RSC medicinal chemistry

|June 24, 2024

概括

再发性子宫内膜癌 (EC) 需要新的治疗方法. 本综述探讨了用于改善EC诊断和治疗的小分子向疗法和光剂.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

子宫内膜癌 (EC) 是女性常见的恶性瘤,其复发构成重大威胁,并导致与癌症相关的死亡率.
目前的标准治疗方法如手术,放射和化疗都有局限性,包括耐药性,需要新的治疗方法.
在了解EC病理生理学的进步已经确定了关键的分子标,如PI3K/Akt/mTOR,PARP,GSK-3β,STAT-3和VEGF.

研究的目的:

审查小分子向治疗子宫内膜癌的进展情况.
探索光特性集成到小分子中,用于联合诊断和治疗.
提供关于EC向治疗的未来方向的见解.

主要方法:

对EC小分子向治疗的基础研究和临床试验的文献综述.
分析已识别的生物点及其在EC瘤信号传递中的作用.
检查光小分子在综合诊断和治疗中的新兴应用.

主要成果:

小分子向疗法在临床前和临床环境中对EC治疗有希望.
几个信号通路 (PI3K/Akt/mTOR,PARP,GSK-3β,STAT-3,VEGF) 是EC治疗的有效标.
光小分子在EC中提供了同时诊断和治疗干预的潜力.

结论:

向治疗是治疗子宫内膜癌的关键进展,解决了传统治疗方法的局限性.
了解EC的分子机制对于开发有效的向治疗方案至关重要.
新型光小分子的开发在欧洲共同体具有个性化和综合性诊断和治疗策略的巨大潜力.

更多相关视频

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...